Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 32

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Aug 28, 2017; 23(32): 5969-5976
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5969

Table 2 Adverse events reported

	Event	Patients
Any adverse event leading to discontinuation	-	0
Serious adverse events	Gastrointestinal bleeding/Portal vein thrombosis and Streptococcus bacteremia/Sinus bradycardia and first degree A-V block with syncope	0
Common adverse events	Fatigue	2
	Diarrhea	1
	Tinnitus	1
	Elevation in serum creatinine	2
	Discomfort of abdomen	1
	Discomfort of transplanted kidney region	1
	Unstable blood pressure	3
	Rash	0
	Insomnia	0
	Headache	0

Citation: Xue Y, Zhang LX, Wang L, Li T, Qu YD, Liu F. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection. World J Gastroenterol 2017; 23(32): 5969-5976
URL: https://www.wjgnet.com/1007-9327/full/v23/i32/5969.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i32.5969

Xue Y, Zhang LX, Wang L, Li T, Qu YD, Liu F. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection. World J Gastroenterol 2017; 23(32): 5969-5976 [PMID: 28932089 DOI: 10.3748/wjg.v23.i32.5969]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.